Standard BioTools Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Standard BioTools Inc. (LAB) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $1.02 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-06
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.02M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.72M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $3.19M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.12M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $1.02M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.72M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.19M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $1.12M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.37M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.09M 10-Q · filed 2017-05-09 |
| 2013-06-30 | $399.00K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $598.00K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |